TC BioPharm (Holdings) plc — key financial figures for fiscal year 2024 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Net Income/Loss (FY2024)

-$15.3M

Total Assets (FY2024)

£8.3M

Total Equity (FY2024)

$3.0M

Cash Flows from Operating Activities (FY2024)

-$12.6M

Source: TC BioPharm (Holdings) plc 20-F filing (FY2024). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.